Fexofenadin-Mepha 120 mg

Fexofenadin-Mepha 120 mg is a medicine authorised by Swissmedic under authorisation number 67369. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 18 July 2019 and the authorisation is valid without a time limit. ATC code R06AX26 places the medicine in the group Antihistamines for systemic use.

  • Dispensing category D
  • Authorisation number 67369
  • ATC R06AX26
  • Synthetic medicines
Authorisation data
Authorisation number67369
NameFexofenadin-Mepha 120 mg
Full nameFexofenadin-Mepha 120 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryD · No prescription, with advice
ATC codeR06AX26
First authorisation18 July 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Fexofenadin-Mepha 120 mg, FilmtablettenD18 July 2019
2Fexofenadin-Mepha 180 mg, FilmtablettenD18 July 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)R06AX2607.13.1.D
230Tablette(n)R06AX2607.13.1.D
550Tablette(n)R06AX2607.13.1.D
310Tablette(n)R06AX2607.13.1.D
430Tablette(n)R06AX2607.13.1.D
650Tablette(n)R06AX2607.13.1.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fexofenadin-Mepha 120 mg authorised in Switzerland?

Yes. Fexofenadin-Mepha 120 mg is authorised by Swissmedic under authorisation number 67369, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fexofenadin-Mepha 120 mg have?

Fexofenadin-Mepha 120 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Fexofenadin-Mepha 120 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com